Generation of leukemia-specific T-helper type 1 cells applicable to human leukemia cell-therapy

Immunol Lett. 2004 Apr 30;93(1):17-25. doi: 10.1016/j.imlet.2004.01.013.

Abstract

Leukemic dendritic cells (DC) were induced from the peripheral blood (PB) or bone marrow (BM) of leukemia patients by culture with (i) GM-CSF + IL-3 (neutral condition); (ii) GM-CSF + IL-3 + IL-12 + IFN-gamma (type 1-condition); or (iii) GM-CSF + IL-3 + IL-4 (type 2-condition). Although leukemic cells rapidly differentiated into adhesive leukemic DC in all culture conditions, type1-conditions were the most suitable for inducing leukemic DC expressing high levels of HLA and costimulatory molecules. Addition of IL-2 after 2 days of culture induced a preferential growth of minor T cell populations interacting with leukemic DC. In particular, IFN-gamma-producing CD4+ Th1 cells were efficiently expanded in type 1 culture conditions but nor in neutral or type 2-conditions. However, CD4+ T cells expanded in neutral conditions showed Th1-like functions if they were pulsed with IFN-gamma for 2 days before harvest. Such Th1 cells produced IFN-gamma and exhibited cytotoxicity in response to autologous leukemia cells. We further demonstrated that IFN-gamma production of leukemia-specific Th1 cells was blocked by anti-HLA-DR mAb. Thus, we established a novel culture system for inducing leukemia-specific Th1 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bone Marrow Cells / immunology
  • Dendritic Cells / immunology
  • Genes, abl
  • Histocompatibility Antigens Class II / immunology
  • Humans
  • In Situ Hybridization, Fluorescence
  • Interferon-gamma / metabolism
  • Leukemia / genetics
  • Leukemia / immunology*
  • Leukemia / therapy*
  • Middle Aged
  • Th1 Cells / immunology*
  • Th1 Cells / metabolism

Substances

  • Histocompatibility Antigens Class II
  • Interferon-gamma